Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
Watson Pharmaceuticals Inc. and Watson Pharma Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2012 | ID-AG | $1,700,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MA-AG | $2,400,000 |
Watson, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2018 | MS-AG | $33,408,547 |
ANDRX PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | environmental violation | 2001 | FL-DEP | $15,000 |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | environmental violation | 2016 | NJ-ENV | $99,800 |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | environmental violation | 2009 | NJ-ENV | $8,900 |
PLIVA INC | Teva Pharmaceutical Industries | environmental violation | 2008 | NJ-ENV | $5,600 |
IVAX PHARMACEUTICALS INC | Teva Pharmaceutical Industries | environmental violation | 2007 | NJ-ENV | $6,000 |
PLIVA INC | Teva Pharmaceutical Industries | environmental violation | 2007 | NJ-ENV | $15,000 |
PLIVA INC | Teva Pharmaceutical Industries | environmental violation | 2006 | NJ-ENV | $7,000 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | environmental violation | 2006 | NJ-ENV | $6,200 |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | environmental violation | 2005 | NJ-ENV | $31,360 |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | environmental violation | 2003 | NJ-ENV | $14,200 |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | environmental violation | 2003 | NJ-ENV | $14,000 |
PLIVA INC | Teva Pharmaceutical Industries | environmental violation | 2002 | NJ-ENV | $41,350 |
Teva Pharmaceuticals Industries Ltd. | Teva Pharmaceutical Industries | product safety violation | 2012 | private lawsuit-federal | $270,000,000 |
Teva Pharmaceutical Industries Ltd. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | TX-AG | $225,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | FL-AG | $278,826,499 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | RI-AG | $21,000,000 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | WV-AG | $83,000,000 |
Teva Pharmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $4,250,000,000 |
Teva Parmaceuticals | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | CA-SFCA | $27,000,000 |
Teva Pharmaceuticals, Ltd. | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | NY-AG | $313,343,793 |
Teva Pharmaceutical Industries | Teva Pharmaceutical Industries | off-label or unapproved promotion of medical products | 2022 | MULTI-AG | $8,200,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,100,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $19,900,000 |
Actavis Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $71,000,000 |
Actavis Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $41,000,000 |
Actavis Mid-Atlantic LLC | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $118,614,000 |
Andrx Corporation | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $55,000,000 |
Barr Laboratories Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2017 | private lawsuit-state | $225,000,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2009 | private lawsuit-federal | $13,000,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $4,150,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
Cephalon Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2020 | private lawsuit-federal | $48,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $512,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2018 | private lawsuit-federal | $27,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $73,000,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $24,000,000 |
Watson Laboratories | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2016 | private lawsuit-state | $50,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $9,615,384 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $27,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $79,000,000 |
DURAMED PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2001 | OSHA | $7,000 |
TEVA PHARMACEUTICALS INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2002 | OSHA | $15,300 |
TEVA SICOR | Teva Pharmaceutical Industries | workplace safety or health violation | 2005 | OSHA | $5,000 |
TEVA PHARMACEUTICAL | Teva Pharmaceutical Industries | workplace safety or health violation | 2000 | OSHA | $5,000 |
BARR LABORATORIES, INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2002 | OSHA | $14,000 |
IVAX PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2002 | OSHA | $15,120 |
PLIVA, INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2003 | OSHA | $19,775 |
BARR LABORATORIES INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2006 | OSHA | $65,250 |
TEVA PHARMACEUTICAL USA, INC. | Teva Pharmaceutical Industries | workplace safety or health violation | 2016 | OSHA | $5,000 |
Watson Laboratories, Inc. | Teva Pharmaceutical Industries | environmental violation | 2004 | EPA | $20,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | environmental violation | 2003 | EPA | $61,158 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
Teva Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | consumer protection violation | 2023 | KY-AG | $1,407,000 |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2023 | DOJ_ANTITRUST | $275,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | FDA | $56,500,000 |
TAP Pharmaceutical Products Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | DOJ_CIVIL | $875,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | DOJ_CIVIL | $350,000,000 |
Shire | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,104,000 |
Shire Pharmaceuticals LLC | Takeda Pharmaceutical | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,786,034 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2008 | AL-AG | $2,000,000 |
Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | AR-AG | $525,780 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | consumer protection violation | 2006 | ID-AG | $198,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | kickbacks and bribery | 2006 | KY-AG | $600,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | kickbacks and bribery | 2006 | WI-AG | $798,000 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
Takeda Pharmaceuticals U.S.A. | Takeda Pharmaceutical | False Claims Act and related | 2019 | IL-AG | $5,833,333 |
Baxalta US Inc. | Takeda Pharmaceutical | wage and hour violation | 2019 | private lawsuit-state | $4,750,000 |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | environmental violation | 2021 | MA-AG | $600,000 |
Baxalta US, Inc. | Takeda Pharmaceutical | environmental violation | 2017 | CA-SCAQMD | $35,000 |
Takeda Pharmaceutical Co. Ltd. | Takeda Pharmaceutical | drug or medical equipment safety violation | 2015 | private lawsuit-federal | $2,400,000,000 |
Shire LLC | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,850,000 |
Shire US Inc. | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $14,750,000 |
Takeda Chemical | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
Takeda Chemical Industries Ltd. | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $22,000,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $150,000,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | benefit plan administrator violation | 2023 | private lawsuit-federal | $22,000,000 |
BAXTER HEALTHCARE CORP DBA BAXTER BIOSCIENCE | Takeda Pharmaceutical | workplace safety or health violation | 2011 | OSHA | $195,000 |
SHIRE CORP | Takeda Pharmaceutical | workplace safety or health violation | 2002 | OSHA | $8,100 |
SHIRE PLC | Takeda Pharmaceutical | workplace safety or health violation | 2016 | OSHA | $19,070 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2023 | TX-AG | $21,350,000 |
Ranbaxy USA Inc. | Sun Pharmaceuticals | drug or medical equipment safety violation | 2013 | FDA | $500,000,000 |
Ranbaxy | Sun Pharmaceuticals | drug or medical equipment safety violation | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $266,729,715 |
Ranbaxy | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Ranbaxy Laboratories | Sun Pharmaceuticals | drug or medical equipment safety violation | 2014 | OR-AG | $2,300,000 |
Ranbaxy Pharmaceuticals, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2014 | NY-AG | $150,000 |
Ranbaxy Pharmaceuticals, Inc. et al. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
Taro Pharmaceutical Industries | Sun Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
DUSA Pharmaceuticals, Inc. | Sun Pharmaceuticals | False Claims Act and related | 2020 | DOJ_CIVIL | $20,750,000 |